摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

isoquinoline-6-sulfonyl chloride

中文名称
——
中文别名
——
英文名称
isoquinoline-6-sulfonyl chloride
英文别名
——
isoquinoline-6-sulfonyl chloride化学式
CAS
——
化学式
C9H6ClNO2S
mdl
MFCD12406172
分子量
227.671
InChiKey
KWADYKRPIUHOTO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    14
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    55.4
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    SUBSTITUTED ISOQUINOLINE DERIVATIVE
    摘要:
    本发明提供了一种作为新型药物剂的异喹啉-6-磺酰胺衍生物。本发明提供了由式(1)表示的异喹啉-6-磺酰胺衍生物,其盐或该衍生物或盐的溶剂:其中X和Y分别独立表示直接键,NH,CH═CH,O或S;R1和R2分别独立表示氢原子,卤素原子,氰基,烷基或类似物;R3和R4分别独立表示氢原子,烷基或类似物,或R3和R4共同形成烷基或烯基,可以在两个碳原子之间被桥接到任意位置;l,m和n表示1到4的整数。
    公开号:
    US20120035159A1
  • 作为产物:
    参考文献:
    名称:
    ISOQUINOLINE SULFONYL CHLORIDE ACID ADDITION SALTS AND METHOD OF MANUFACTURE THEREOF
    摘要:
    一种化合物,如异喹啉-6-磺酰氯酸和/或其盐,可能用作异喹啉-6-磺酰胺化合物的制造中间体。制造这种化合物和/或其酸盐的方法可能涉及将6-(苄硫基)异喹啉置于氧化氯化反应中,和/或将6-氨基异喹啉与亚硝酸盐或亚硝酸酯反应,然后与氯化亚砜反应,最后与酸反应。
    公开号:
    US20210395205A1
点击查看最新优质反应信息

文献信息

  • Convenient preparation of aryl ether derivatives using a sequence of functionalized polymers
    作者:Mike E. Lizarzaburu、Stephen J. Shuttleworth
    DOI:10.1016/s0040-4039(03)01117-1
    日期:2003.6
    A four-step synthesis to aryl ether derivatives, three of which utilize polymer-supported reagents, has been developed. Supported triphenylphosphine was successfully utilized in two distinct synthetic processes in the first step, whilst supported base and ionic and covalent scavengers were employed to complete the synthesis and purification of the target compounds.
    已开发出四步合成芳基醚衍生物的方法,其中三步使用聚合物负载的试剂。在第一步中,成功地将负载的三苯膦用于两个不同的合成过程中,同时使用负载的碱和离子和共价清除剂来完成目标化合物的合成和纯化。
  • NOVEL SUBSTITUTED ISOQUINOLINE DERIVATIVE
    申请人:Hidaka Hiroyoshi
    公开号:US20130274269A1
    公开(公告)日:2013-10-17
    The present invention provides a novel isoquinoline-6-sulfonamide derivative that is useful as a medicine. The present invention provides an isoquinoline-6-sulfonamide derivative represented by Formula (1), a salt thereof, or a solvate of the derivative or the salt, wherein R 1 and R 2 each independently represent a hydrogen atom, or the like; R 3 and R 4 each independently represent a hydrogen atom, an alkyl group, or the like; R 5 represents a hydrogen atom, an optionally substituted alkyl group, an optionally substituted alkenyl group, an optionally substituted alkynyl group, an optionally substituted cycloalkyl group, an optionally substituted alkanoyl group, or the like; and A represents a linear or branched alkylene group having 2 to 6 carbon atoms.
    本发明提供了一种新型的异喹啉-6-磺酰胺衍生物,该衍生物可用作药物。本发明提供了一种由公式(1)表示的异喹啉-6-磺酰胺衍生物,其盐,或衍生物或盐的溶剂化物,其中R1和R2各自独立地代表氢原子或类似物;R3和R4各自独立地代表氢原子、烷基或类似物;R5代表氢原子、可选地取代的烷基、可选地取代的烯基、可选地取代的炔基、可选地取代的环烷基、可选地取代的烷酰基或类似物;A代表具有2至6个碳原子的直链或支链亚烷基。
  • 1,4-DIAZOCANE COMPOUND OR SALT THEREOF
    申请人:D. WESTERN THERAPEUTICS INSTITUTE, INC.
    公开号:US20210371396A1
    公开(公告)日:2021-12-02
    A method may produce an isoquinoline-6-sulfonamide derivative useful as a medicinal drug; and an intermediate which is used for the method, and more specifically, a 1,4-diazocane compound of formula (8), wherein R 4 is an amino protecting group, or a salt thereof.
    一种方法可能产生一种对医药有用的异喹啉-6-磺酰胺衍生物;以及用于该方法的中间体,更具体地说,是一种化合物的1,4-二氮杂环庚烷(8)的公式,其中R4是氨基保护基,或其盐。
  • Substituted isoquinoline derivative
    申请人:Hidaka Hiroyoshi
    公开号:US08951997B2
    公开(公告)日:2015-02-10
    The present invention provides an isoquinoline-6-sulfonamide derivative that is useful as a novel pharmaceutical agent. The present invention provides an isoquinoline-6-sulfonamide derivative represented by Formula (1), a salt thereof, or a solvate of the derivative or the salt: wherein X and Y each independently represent a direct bond, NH, CH═CH, O, or S; R1 and R2 each independently represent a hydrogen atom, a halogen atom, a cyano group, an alkyl group, or the like; R3 and R4 each independently represent a hydrogen atom, an alkyl group, or the like, or R3 and R4 together form an alkylene group or an alkenylene group, which may be bridged between two carbon atoms to an arbitrary position; and l, m, and n represent an integer number of 1 to 4.
    本发明提供了一种作为新型药物的异喹啉-6-磺酰胺衍生物。本发明提供了由式(1)表示的异喹啉-6-磺酰胺衍生物、其盐或衍生物或盐的溶剂:其中X和Y各自独立地表示直接键,NH,CH═CH,O或S;R1和R2各自独立地表示氢原子、卤素原子、氰基、烷基或类似物;R3和R4各自独立地表示氢原子、烷基或类似物,或者R3和R4一起形成一个烷基或烯基,可以在任意位置与两个碳原子之间桥接;l、m和n表示1到4的整数。
  • ISOQUINOLINESULFONYL CHLORIDE ACID ADDITION SALT AND METHOD FOR PRODUCING SAME
    申请人:D. Western Therapeutics Institute, Inc.
    公开号:EP3900724A1
    公开(公告)日:2021-10-27
    Provided is a compound that is useful as a manufacturing intermediate for an isoquinoline-6-sulfonamide compound and a method for its manufacture, and more specifically isoquinoline-6-sulfonyl chloride acid addition salts.
    本文提供了一种可用作异喹啉-6-磺酰胺化合物制造中间体的化合物及其制造方法,更具体地说是异喹啉-6-磺酰氯酸加成盐。
查看更多